Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin
Aaron J. Smith*, John Oertle, Dino Prato
Envita, Scottsdale, USA.
DOI: 10.4236/jct.2015.63029   PDF    HTML   XML   4,343 Downloads   6,608 Views   Citations


Curcumin is a naturally occurring phytotherapeutic that has broad uses including the treatment of cancer and as a potent antimicrobial agent. Its dynamic ability to treat very different kinds of disease has spawned a significant increase in inquiry on how curcumin accomplishes these feats. Thousands of peer reviewed papers were published in the past few years regarding the various functions of curcumin. Unlike most pharmaceuticals, curcumin has a multi-range of different targets that it interacts with. Since curcumin’s bioavailabilty is limited, methods of increasing curcumin’s bioavailabilty are discussed. Mechanisms of action regarding curcumin’s ability to effect cancer are discussed including upstream and downstream mechanisms starting with epigenetics to its effect on signal transduction pathways and apoptosis. Curcumin also works adjuvantly with chemotherapy to reduce resistance and enhance the mechanism of certain chemotherapeutic agents. Curcumin’s antibacterial, antifungal, and antiviral capability is also discussed with regard to curcumin’s dynamic ability to treat infections. Curcumin use in cancer adjunctive care and its anti-infectious capabilities make it a unique phytotherapeutic agent with promise.

Share and Cite:

Smith, A. , Oertle, J. and Prato, D. (2015) Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin. Journal of Cancer Therapy, 6, 257-272. doi: 10.4236/jct.2015.63029.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Corson, T.W. and Crews, C.M. (2007) Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials. Cell, 130, 769-774.
[2] Singh, S. (2007) From Exotic Spice to Modern Drug? Cell, 130, 765-768.
[3] Sawan, C., Vaissiere, T., Murr, R., Herceg, Z. (2008) Epigenetic Drivers and Genetic Passengers on the Road to Cancer. Mutation Research, 642, 1-13.
[4] Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., et al. (1999) Synergy of Demethylation and Histone Deacetylase Inhibition in the Re-Expression of Genes Silenced in Cancer. Nature Genetics, 21, 103-107.
[5] Davis, C.D. and Ross, S.A. (2007) Dietary Components Impact Histone Modifications and Cancer Risk. Nutrition Reviews, 65, 88-94.
[6] Ehrlich, M. (2009) DNA Hypomethylation in Cancer Cells. Epigenomics, 1, 239-259.
[7] Kulis, M. and Esteller, M. (2010) DNA Methylation and Cancer. Advances in Genetics, 70, 27-56.
[8] Mani, S. and Herceg, Z. (2010) DNA Demethylating Agents and Epigenetic Therapy of Cancer. Advances in Genetics, 70, 327-340.
[9] Strahl, B.D. and Allis, C.D. (2000) The Language of Covalent Histone Modifications. Nature, 403, 41-45.
[10] Bannister, A.J. and Kouzarides, T. (2011) Regulation of Chromatin by Histone Modifications. Cell Research, 21, 381-395.
[11] Kouzarides, T. (2007) Chromatin Modifications and Their Function. Cell, 128, 693-705.
[12] Sawan, C. and Herceg, Z. (2010) Histone Modifications and Cancer. Advances in Genetics, 70, 57-85.
[13] Vandenboom II, T.G., Li, Y., Philip, P.A. and Sarkar, F.H. (2008) MicroRNA and Cancer: Tiny Molecules with Major Implications. Current Genomics, 9, 97-109.
[14] Fabbri, M. and Calin, G.A. (2010) Epigenetics and miRNAs in Human Cancer. Advances in Genetics, 70, 87-99.
[15] Winter, J. and Diederichs, S. (2011) MicroRNA Biogenesis and Cancer. Methods in Molecular Biology, 676, 3-22.
[16] Shu, L., Khor, T.O., Lee, J.H., Boyanapalli, S.S., Huang, Y., Wu, T.Y., et al. (2011) Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells. AAPS Journal, 13, 606-614.
[17] Liu, Z., Xie, Z., Jones, W., Pavlovicz, R.E., Liu, S.J., Yu, J.H., et al. (2009) Curcumin Is a Potent DNA Hypomethylation Agent. Bioorganic & Medicinal Chemistry Letters, 19, 706-709.
[18] Parashar, G., Parashar, N.C. and Capalash, N. (2012) Curcumin Causes Promoter Hypomethylation and Increased Expression of FANCF Gene in SiHa Cell Line. Molecular and Cellular Biochemistry, 365, 29-35.
[19] Abusnina, A., Keravis, T., Yougbare, I., Bronner, C. and Lugnier, C. (2011) Anti-Proliferative Effect of Curcumin on Melanoma Cells Is Mediated by PDE1A Inhibition that Regulates the Epigenetic Integrator UHRF1. Molecular Nutrition & Food Research, 55, 1677-1689.
[20] Du, L., Xie, Z., Wu, L.C., Chiu, M., Lin, J., Chan, K.K., et al. (2012) Reactivation of RASSF1A in Breast Cancer Cells by Curcumin. Nutrition and Cancer, 64, 1228-1235.
[21] Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G.R., et al. (2011) Curcumin Modulates MicroRNA-203-Mediated Regulation of the Src-Akt Axis in Bladder Cancer. Cancer Prevention Research, 4, 1698-1709.
[22] Strahl, B.D. and Allis, C.D. (2000) The Language of Covalent Histone Modifications. Nature, 403, 41-45.
[23] Bannister, A.J. and Kouzarides, T. (2011) Regulation of Chromatin by Histone Modifications. Cell Research, 21, 381-395.
[24] Manzo, F., Tambaro, F.P., Mai, A. and Altucci, L. (2009) Histone Acetyltransferase Inhibitors and Preclinical Studies. Expert Opinion on Therapeutic Patents, 19, 761-774.
[25] Shankar, S. and Srivastava, R.K. (2007) Involvement of Bcl-2 Family Members, Phosphatidylinositol 3’-Kinase/AKT and Mitochondrial P53 in Curcumin (Diferulolylmethane)-Induced Apoptosis in Prostate Cancer. International Journal of Oncology, 30, 905-918.
[26] Kang, S.K., Cha, S.H. and Jeon, H.G. (2006) Curcumin-Induced Histone Hypoacetylation Enhances Caspase-3-Dependent Glioma Cell Death and Neurogenesis of Neural Progenitor Cells. Stem Cells and Development, 15, 165-174.
[27] Yuan, Z., Syed, M.A., Panchal, D., Rogers, D., Joo, M. and Sadikot, R.T. (2012) Curcumin Mediated Epigenetic Modulation Inhibits TREM-1 Expression in Response to Lipopolysaccharide. International Journal of Biochemistry & Cell Biology, 44, 2032-2043.
[28] Yun, J.M., Jialal, I. and Devaraj, S. (2011) Epigenetic Regulation of High Glucose-Induced Proinflammatory Cytokine Production in Monocytes by Curcumin. Journal of Nutritional Biochemistry, 22, 450-458.
[29] Croce, C.M. (2009) Causes and Consequences of MicroRNA Dysregulation in Cancer. Nature Reviews Genetics, 10, 704-714.
[30] Karius, T., Schnekenburger, M., Dicato, M. and Diederich, M. (2012) MicroRNAs in Cancer Management and Their Modulation by Dietary Agents. Biochemical Pharmacology, 83, 1591-1601.
[31] Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., et al. (2004) Human MicroRNA Genes Are Frequently Located at Fragile Sites and Genomic Regions Involved in Cancers. Proceedings of the National Academy of Sciences of the United States of America, 101, 2999-3004.
[32] Negrini, M., Ferracin, M., Sabbioni, S. and Croce, C.M. (2007) MicroRNAs in Human Cancer: From Research to Therapy. Journal of Cell Science, 120, 1833-1840.
[33] Li, Y., Kong, D., Wang, Z. and Sarkar, F.H. (2010) Regulation of MicroRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research. Pharmaceutical Research, 27, 1027-1041.
[34] Yang, J., Cao, Y., Sun, J. and Zhang, Y. (2010) Curcumin Reduces the Expression of Bcl-2 by Upregulating miR-15a and miR-16 in MCF-7 Cells. Medical Oncology, 27, 1114-1118.
[35] Gao, S.M., Yang, J.J., Chen, C.Q., Chen, J.J., Ye, L.P., Wang, L.Y., et al. (2012) Pure Curcumin Decreases the Expression of WT1 by Upregulation of miR-15a and miR-16-1 in Leukemic Cells. Journal of Experimental & Clinical Cancer Research, 31, 27.
[36] Tang, N., Zhang, J. and Du, Y. (2010) Curcumin Promoted the Apoptosis of Cisplain-Resistant Human Lung Carcinoma Cells A549/DDP through Down-Regulating miR-186*. Zhongguo Fei Ai Za Zhi, 13, 301-306.
[37] Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C.G., Ren, X.L. and Yin, H. (2010) Curcumin Promotes Apoptosis in A549/ DDP Multidrug-Resistant Human Lung Adenocarcinoma Cells through an miRNA Signaling Pathway. Biochemical and Biophysical Research Communications, 399, 1-6.
[38] Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J.M., et al. (2010) Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF. Cancer Research, 70, 3606-3617.
[39] Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R.J., Anant, S. and Sharma, P. (2012) Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling. PLoS ONE, 7, e30590.
[40] Tan, B.T., Park, C.Y., Ailles, L.E. and Weissman, I.L. (2006) The Cancer Stem Cell Hypothesis: A Work in Progress. Laboratory Investigation, 86, 1203-1207.
[41] Polyak, K. and Hahn, W.C. (2006) Roots and Stems: Stem Cells in Cancer. Nature Medicine, 12, 296-300.
[42] Kakarala, M., Brenner, D.E., Korkaya, H., Cheng, C., Tazi, K., Ginestier, C., et al. (2010) Targeting Breast Stem Cells with the Cancer Preventive Compounds Curcumin and Piperine. Breast Cancer Research and Treatment, 122, 777-785.
[43] Nautiyal, J., Kanwar, S.S., Yu, Y. and Majumdar, A.P. (2011) Combination of Dasatinib and Curcumin Eliminates Chemo-Resistant Colon Cancer Cells. Journal of Molecular Signaling, 6, 7.
[44] Yu, Y., Kanwar, S.S., Patel, B.B., Nautiyal, J., Sarkar, F.H. and Majumdar, A.P. (2009) Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology, 2, 321-328.
[45] Fong, D., Yeh, A., Naftalovich, R., Choi, T.H. and Chan, M.M. (2010) Curcumin Inhibits the Side Population (SP) Phenotype of the Rat C6 Glioma Cell Line: Towards Targeting of Cancer Stem Cells with Phytochemicals. Cancer Letters, 293, 65-72.
[46] Pastrana, E., Silva-Vargas, V. and Doetsch, F. (2011) Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells. Cell Stem Cell, 8, 486-498.
[47] Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S.R., Wesselborg, S., Schulze-Osthoff, K. and Los, M. (2008) Cancer Stem Cell Markers in Common Cancers: Therapeutic Implications. Trends in Molecular Medicine, 14, 450-460.
[48] Li, L., Ahmed, B., Mehta, K. and Kurzrock, R. (2007) Liposomal Curcumin with and without Oxaliplatin: Effects on Cell Growth, Apoptosis, and Angiogenesis in Colorectal Cancer. Molecular Cancer Therapeutics, 6, 1276-1282.
[49] Howells, L.M., Mitra, A. and Manson, M.M. (2007) Comparison of Oxaliplatin- and Curcumin-Mediated Antiproliferative Effects in Colorectal Cell Lines. International Journal of Cancer (Journal International Du Cancer), 121, 175-183.
[50] Howells, L.M., Sale, S., Sriramareddy, S.N., Irving, G.R., Jones, D.J.L., Ottley, C.J., et al. (2011) Curcumin Ameliorates Oxaliplatin-Induced Chemoresistance in HCT116 Colorectal Cancer Cells in Vitro and in vivo. International Journal of Cancer, 129, 476-486.
[51] Harbottle, A., Daly, A.K., Atherton, K. and Campbell, F.C. (2001) Role of Glutathione S-Transferase P1, P-Glycoprotein and Multidrug Resistance-Associated Protein 1 in Acquired Doxorubicin Resistance. International Journal of Cancer (Journal International Du Cancer), 92, 777-783.
[52] Patel, B.B., Sengupta, R., Qazi, S., Vachhani, H., Yu, Y.J., Rishi, A.K. and Majumdar, A.P.N. (2008) Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Mediating Growth Inhibition of Colon Cancer Cells by Modulating EGFR and IGF-1R. International Journal of Cancer (Journal International Du Cancer), 122, 267-273.
[53] Liu, H., Zhou, B.H., Qiu, X., Wang, H.S., Zhang, F., Fang, R., et al. (2012) T63, a New 4-Arylidene Curcumin Analogue, Induces Cell Cycle Arrest and Apoptosis through Activation of the Reactive Oxygen Species-FOXO3a Pathway in Lung Cancer Cells. Free Radical Biology and Medicine, 53, 2204-2217.
[54] Chen, L., Tian, G.Q., Shao, C.X., Cobos, E. and Gao, W.M. (2010) Curcumin Modulates Eukaryotic Initiation Factors in Human Lung Adenocarcinoma Epithelial Cells. Molecular Biology Reports, 37, 3105-3110.
[55] Xu, Y., Zhang, J.J., Han, J., Pan, X.Y., Cao, Y.J., Guo, H., et al. (2012) Curcumin Inhibits Tumor Proliferation Induced by Neutrophil Elastase through the Upregulation of Alpha1-Antitrypsin in Lung Cancer. Molecular Oncology, 6, 405-417.
[56] Chen, Q.Y., Jiao, D.M., Yao, Q.H., Yan, J., Song, J., Chen, F.Y., Lu, G.H. and Zhou, J.Y. (2012) Expression Analysis of Cdc42 in Lung Cancer and Modulation of Its Expression by Curcumin in Lung Cancer Cell Lines. International Journal of Oncology, 40, 1561-1568.
[57] Bachmeier, B.E., Killian, P., Pfeffer, U. and Nerlich, A.G. (2010) Novel Aspects for the Application of Curcumin in Chemoprevention of Various Cancers. Frontiers in Bioscience (Schol Ed), 2, 697-717.
[58] Shehzad, A. and Lee, Y.S. (2010) Curcumin: Multiple Molecular Targets Mediate Multiple Pharmacological Actions: A Review. Drugs of the Future, 35, 113-119.
[59] Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B. and Aggarwal, B.B. (2008) Curcumin and Cancer: An “Old-Age” Disease with an “Age-Old” Solution. Cancer Letters, 267, 133-164.
[60] Sun, S.H., Huang, H.C., Huang, C. and Lin, J.K. (2012) Cycle Arrest and Apoptosis in MDA-MB-231/Her2 Cells Induced by Curcumin. European Journal of Pharmacology, 690, 22-30.
[61] Zhang, H.G., Kim, H., Liu, C., Yu, S., Wang, J., et al. (2007) Curcumin Reverses Breast Tumor Exosomes Mediated Immune Suppression of NK Cell Tumor Cytotoxicity. Biochimica et Biophysica Acta, 1773, 1116-1123.
[62] Shishodia, S., Chaturvedi, M.M. and Aggarwal, B.B. (2007) Role of Curcumin in Cancer Therapy. Current Problems in Cancer, 31, 243-305.
[63] Shehzad, A., Khan, S., Shehzad, O. and Lee, Y.S. (2010) Curcumin Therapeutic Promises and Bioavailability in Colorectal Cancer. Drugs of Today, 46, 523-532.
[64] He, Z.Y., Shi, C.B., Wen, H., Li, F.L., Wang, B.L. and Wang, J. (2011) Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin. Cancer Investigation, 29, 208-213.
[65] Aggarwal, B.B. (2008) Prostate Cancer and Curcumin: Add Spice to Your Life. Cancer Biology & Therapy, 7, 1436-1440.
[66] Dorai, T., Cao, Y.C., Dorai, B., Buttyan, R. and Katz, A.E. (2001) Therapeutic Potential of Curcumin in Human Prostate Cancer. III. Curcumin Inhibits Proliferation, Induces Apoptosis, and Inhibits Angiogenesis of LNCaP Prostate Cancer Cells in vivo. Prostate, 47, 293-303.
[67] Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P. and Aggarwal, B.B. (2001) Curcumin Downregulates Cell Survival Mechanisms in Human Prostate Cancer Cell Lines. Oncogene, 20, 7597-7609.
[68] Sundram, V., Chauhan, S.C., Ebeling, M. and Jaggi, M. (2012) Curcumin Attenuates β-Catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1. PLoS ONE, 7, e35368.
[69] Lin, Y.G., Kunnumakkara, A.B., Nair, A., Merritt, W.M., Han, L.Y., et al. (2007) Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway. Clinical Cancer Research, 13, 3423-3430.
[70] Watson, J.L., Greenshields, A., Hill, R., Hilchie, A., Lee, P.W., Giacomantonio, C.A. and Hoskin, D.W. (2010) Curcumin-Induced Apoptosis in Ovarian Carcinoma Cells Is p53-Independent and Involves p38 Mitogen-Activated Protein Kinase Activation and Downregulation of Bcl-2 and Survivin Expression and Akt Signaling. Molecular Carcinogenesis, 49, 13-24.
[71] Mukherjee, N., Chakraborty, S., Ghosh, U., Bhattacharyya, N.P., Bhattacharya, R.K., Dey, S. and Roy, M. (2007) Curcumin-Induced Apoptosis in Human Leukemia Cell HL-60 Is Associated with Inhibition of Telomerase Activity. Molecular and Cellular Biochemistry, 297, 31-39.
[72] Ghosh, A.K., Kay, N.E., Secreto, C.R. and Shanafelt, T.D. (2009) Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG. Clinical Cancer Research, 15, 1250-1258.
[73] Yang, C.W., Chang, C.L., Lee, H.C., Chi, C.W., Pan, J.P. and Yang, W.C. (2012) Curcumin Induces the Apoptosis of Human Monocytic Leukemia THP-1 Cells via the Activation of JNK/ERK Pathways. BMC Complementary and Alternative Medicine, 12, 22.
[74] Bharti, A.C., Donato, N. and Aggarwal, B.B. (2003) Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells. Journal of Immunology, 171, 3863-3871.
[75] Bharti, A.C., Donato, N., Singh, S. and Aggarwal, B.B. (2003) Curcumin (Diferuloylmethane) Down-Regulates the Constitutive Activation of Nuclear Factor-κB and IκBα Kinase in Human Multiple Myeloma Cells, Leading to Suppression of Proliferation and Induction of Apoptosis. Blood, 101, 1053-1062.
[76] Sung, B., Kunnumakkara, A.B., Sethi, G., Anand, P., Guha, S. and Aggarwal, B.B. (2009) Curcumin Circumvents Chemoresistance in Vitro and Potentiates the Effect of Thalidomide and Bortezomib against Human Multiple Myeloma in Nude Mice Model. Molecular Cancer Therapeutics, 8, 959-970.
[77] Vadhan, R.S., Weber, D., Giralt, S., Alexanian, R., Thomas, S., et al. (2007) Curcumin Downregulates NF-κB and Related Genes in Patients with Multiple Myeloma: Results of a Phase I/II Study. Blood (ASH Annual Meeting Abstracts), 110, 1177a.
[78] Golombick, T., Diamond, T.H., Manoharan, A. and Ramakrishna, R. (2012) Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, and Curcumin: A Randomized, Double-Blind Placebo-Controlled Cross-Over 4g Study and an Open-Label 8g Extension Study. American Journal of Hematology, 87, 455-460.
[79] Pluen, A., Boucher, Y., Ramanujan, S., Mckee, T.D., Gohongi, T., Di Tomaso, E., Brown, E.B., Izumi, T., Campbell, R.B., Berk, D.A. and Jain, R.K. (2001) Role of Tumor-Host Interactions in Interstitial Diffusion of Macromolecules: Cranial vs. Subcutaneous Tumors. Proceedings of the National Academy of Sciences of the United States of America, 98, 4628-4633.
[80] Diaconu, C.C., Szathmari, M., Keri, G. and Venetianer, A. (1999) Apoptosis Is Induced in both Drug-Sensitive and Multidrug-Resistant Hepatoma Cells by Soatostatin Analogue RR-232. British Journal of Cancer, 80, 1197-1203.
[81] Cheah, Y.H., Nordin, F.J., Sarip, R., Tee, T.T., Azimahtol, H.L., Sirat, H.M., Rashid, B.A., Adbullah, N.R. and Ismail, Z. (2009) Combined Xanthorrhizol-Curcumin Exhibits Synergistic Growth Inhibitory Activity via Apoptosis Induction in Human Breast Cancer Cells MDA-MB-231. Cancer Cell International, 9, 1.
[82] Siddiqui, I.A., Malik, A., Adhami, V.M., Asim, M., Hafees, B.B., Sarfaraz, S. and Mukhtar, H. (2008) Green Tea Polyphenol EGCG Sensitizes Human Prostate Carcinoma LNCaP Cells to TRAIL-Mediated Apoptosis and Synergistically Inhibits Biomarkers Associated with Angiogenesis and Metastasis. Oncogene, 27, 2055-2063.
[83] Strimpakos, A.S. and Sharma, R.A. (2008) Curcumin: Preventative and Therapeutic Properties in Laboratory Studies and Clinical Trials. Antioxidants & Redox Signaling, 10, 511-546.
[84] PAL, S., Bhattacharyys, S., Choudhuri, T., Datta, G.K., Das, T. and Sa, G. (2005) Amelioration of Immune Cell Number Depletion and Potentiation of Depressed Detoxification System of Tumor-Bearing Mice by Curcumin. Cancer Detection and Prevention, 29, 470-478.
[85] Pal, S., Choudhuri, T., Chattopadjyay, S., Bhattacharya, A., Datta, G.K., Das, T. and Sa, G. (2001) Mechanisms of Curcumin-Induced Apoptosis of Ehrlich’s Ascites Carcinoma Cells. Biochemical and Biophysical Research Communications, 288, 658-665.
[86] Chakraborty, J., Banerjee, S., Ray, P., Hossain, D.M., Bhattacharyya, S., Adhikary, A., Chattopadhyay, S., Das, T. and Sa, G. (2010) Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells. Journal of Biological Chemistry, 285, 33104-33112.
[87] Choudhuri, T., Pal, S., Das, T. and Sa, G. (2005) Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1 Expressed Cells at G2 Phase of Cell Cycle in p53-Dependent Manner. Journal of Biological Chemistry, 280, 20059-20068.
[88] Choudhuri, T., Pal, S., Agwarwal, M.L., Das, T. and Sa, G. (2002) Curcumin Induces Apoptosis in Human Breast Cancer Cells through p53-Dependent Bax Induction. FEBS Letters, 512, 334-340.
[89] Bhattacharyya, S., Mandal, D., Saha, B., Sen, G.S., Das, T. and Sa, G. (2007) Curcumin Prevents Tumor-Induced T Cell Apoptosis through Stat-5a-Mediated Bcl-2 Induction. Journal of Biological Chemistry, 282, 15954-15964.
[90] Pal, S., Bhattacharyya, S., Choudhuri, T., Datta, G.K., Das, T. and Sa, G. (2005) Amelioration of Immune Cell Number Depletion and Potentiation of Depressed Detoxification System of Tumor-Bearing Mice by Curcumin. Cancer Detection and Prevention, 29, 470-478.
[91] Bhattacharyya, S., Mandal, D., Sen, G.S., Pal, S., Banerjee, S., Hahiry, L., Finke, J.H., Tannenbaum, C.S., Das, T. and Sa, G. (2007) Tumor-Induced Oxidative Stress Perturbs Nuclear Factor-κB Activity-Augmenting Tumor Necrosis Factor-α-Mediated T-Cell Death: Protection by Curcumin. Cancer Research, 67, 362-370.
[92] Bhattacharyya, S., Md Sakib Hossain, D., Mahanty, S., Sankar Sen, G., Chattopadhyay, S., Banerjee, S., Chakraborty, J., Das, K., Sarkar, D., Das, T. and Sa, G. (2010) Curcumin Reverses T Cell-Mediated Adaptive Immune Dysfunctions in Tumor Bearing Hosts. Cellular & Molecular Immunology, 7, 306-315.
[93] Sharma, S.K., George, N., Kadhiravan, T., Saha, P.K., Mishra, H.K. and Hanif, M. (2009) Prevalence of Extensively Drug-Resistant Tuberculosis among Patients with Multidrug-Resistant Tuberculosis: A Retrospective Hospital Based Study. Indian Journal of Medical Research, 130, 392-395.
[94] Anuchapreeda, S., Leechanachai, P., Smith, M.M., Amubudkar, S.V. and Limtrakul, P.N. (2002) Modulation of P-Glycoprotein Expression and Function by Curcumin in Multidrug-Resistant Human KB Cells. Biochemical Pharmacology, 64, 573-582.
[95] Chearwae, W., Shukla, S., Limtrakul, P. and Ambudkar, S.V. (2006) Modulation of the Function of the Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2 by the Cancer Chemopreventive Agent Curcumin. Molecular Cancer Therapeutics, 5, 1995-2006.
[96] Chearwae, W., Wu, C.P., Chu, H.Y., Lee, T.R., Ambudkar, S.V. and Limtrakul, P. (2006) Curcuminoids Purified from Turmeric Powder Modulate the Function of Human Multidrug-Resistance Protein 1 (ABCC1). Cancer Chemotherapy and Pharmacology, 57, 376-388.
[97] Sharma, M., Manoharlal, R., Shukla, S., Puri, N., Prasad, R., Ambudkar, S.V. and Prasad, R. (2009) Curcumin Modulates Efflux Mediated by Yeast ABC Multidrug Transporter and Is Synergistic with Antifungals. Antimicrobial Agents and Chemotherapy, 53, 3256-3265.
[98] Khopde, S.M., Priyadarsini, K.I., Venkatesan, P. and Rao, M.N. (1999) Free Radical Scavenging Ability and Antioxidant Efficiency of Curcumin and Its Substituted Analogue. Biophysical Chemistry, 80, 85-91.
[99] Kuttan, G., Kumar, K.B., Guruvayoorappan, C. and Kuttan, R. (2007) Antitumor, Anti-Invasion, and Antimetastatic Effects of Curcumin. Advances in Experimental Medicine and Biology, 595, 173-184.
[100] Limtrakul, P., Anuchapreeda, S. and Buddhasukh, D. (2004) Modulation of Human Multidrug-Resistance MDR-1 Gene by Natural Curcuminoids. BMC Cancer, 4, 13.
[101] Wahl, H., Tan, L., Griffith, K., Choi, M. and Liu, J.R. (2007) Curcumin Enhances Apo2L/TRAIL-Induced Apoptosis in Chemoresistant Ovarian Cancer Cells. Gynecologic Oncology, 105, 104-112.
[102] Deeb, D., Xu, Y.X., Jiang, H., Gao, X., Janakiraman, N., Chapman, R.A. and Gautam, S.C. (2003) Curcumin (Diferuloyl-Methane) Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in LNCaP Prostate Cancer Cells. Molecular Cancer Therapeutics, 2, 95-103.
[103] Deeb, D.D., Jiang, H., Gao, X., Divine, G., Dulchavsky, S.A. and Gautam, S.C. (2005) Chemosensitization of Hormone-Refractory Prostate Cancer Cells by Curcumin to TRAIL-Induced Apoptosis. Journal of Experimental Therapeutics & Oncology, 5, 81-91.
[104] Deeb, D., Jiang, H., Gao, X., Al-Holou, S., Danylik, A.L., Dulchavsky, S.A. and Gautam, S.C. (2007) Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione, C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-κB via Inhibition of the Prosurvival Akt Signaling Pathway. Journal of Pharmacology and Experimental Therapeutics, 321, 616-625.
[105] Gao, X., Deeb, D., Jiang, H., Liu, Y.B., Dulchavsky, S.A. and Gautam, S.C. (2005) Curcumin Differentially Sensitizes Malignant Glioma Cells to TRAIL/Apo2L-Mediated Apoptosis through Activation of Procaspases and Release of Cytochrome C from Mitochondria. Journal of Experimental Therapeutics and Oncology, 5, 39-48.
[106] Shankar, S., Ganapathy, S., Chen, Q. and Srivastava, R.K. (2008) Curcumin Sensitizes TRAIL-Resistant Xenografts: Molecular Mechanisms of Apoptosis, Metastasis and Angiogenesis. Molecular Cancer, 7, 16.
[107] Jagetia, G.C. and Aggarwal, B.B. (2007) “Spicing Up” of the Immune System by Curcumin. Journal of Clinical Immunology, 27, 19-35.
[108] Dhandapani, K.M., Mahesh, V.B. and Brann, D.W. (2007) Curcumin Suppresses Growth and Chemoresistance of Human Glioblastoma Cells via AP-1 and NFκB Transcription Factors. Journal of Neurochemistry, 102, 522-538.
[109] Woo, J.H., Kim, Y.H., Choi, Y.J., KIM, D.G., Lee, K.S., Bae, J.H., Min, D.S., Chang, J.S., Jeong, Y.J., Lee, Y.H., Park, J.W. and Kwon, T.K. (2003) Molecular Mechanisms of Curcumin-Induced Cytotoxicity: Induction of Apoptosis through Generation of Reactive Oxygen Species, Down-Regulation of Bcl-XL and IAP, the Release of Cycochrome C and Inhibition of Akt. Carcinogenesis, 24, 1199-1208.
[110] Goel, A., Kunnumakkara, A.B. and Aggarwal, B.B. (2008) Curcumin as “Curecumin”: From Kitchen to Clinic. Biochemical Pharmacology, 75, 787-809.
[111] Abe, Y., Hashimoto, S. and Horie, T. (1999) Curcumin Inhibition of Inflammatory Cytokine Production by Human Peripheral Blood Monocytes and Alveolar Macrophages. Pharmacological Research, 39, 41-47.
[112] Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K. and Lee, S.S. (2001) Molecular Mechanisms Underlying Chemopreventive Activities of Anti-Inflammatory Phytochemicals: Down-Regulation of COX-2 and iNOS through Suppression of NF-Kappa B Activation. Mutation Research, 480-481, 243-268.
[113] Jobin, C., Bradham, C.A., Russo, M.P., Juma, B., Narula, A.S., Brenner, D.A. and Sartor, R.B. (1999) Curcumin Blocks Cytokine-Mediated NF-Kappa B Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-Kappa B Kinase Activity. Journal of Immunology, 163, 3474-3483.
[114] Huang, M.T., Lysz, T., Ferraro, T., Abidi, T.F., Laskin, J.D. and Conney, A.H. (1991) Inhibitory Effects of Curcumin on in Vitro Lipoxygenase and Cyclooxygenase Activities in Mouse Epidermis. Cancer Research, 51, 813-819.
[115] Bennett, A. (1986) The Production of Prostanoids in Human Cancers, and Their Implications for Tumor Progression. Progress in Lipid Research, 25, 539-542.
[116] Qiao, L., Kozoni, V., Tsioulias, G.J., Koutsos, M.I., Hanif, R., Shiff, S.J. and Rigas, B. (1995) Selected Eicosanoids Increase the Proliferation Rate of Human Colon Carcinoma Cell Lines and Mouse Colonocytes in vivo. Biochimica et Biophysica Acta, 1258, 215-223.
[117] Aggarwal, B.B., Kumar, A. and Bharti, A.C. (2003) Anticancer Potential of Curcumin: Preclinical and Clinical Studies. Anticancer Research, 23, 363-398.
[118] Liu, J.Y., Lin, S.J. and Lin, J.K. (1993) Inhibitory Effects of Curcumin on Protein Kinase C Activity Induced by 12-O-Tetradecanoyl-Phorbol-13-Acetate in NIH 3T3 Cells. Carcinogenesis, 14, 857-861.
[119] Cho, J.W., Lee, K.S. and Kim, C.W. (2007) Curcumin Attenuates the Expression of IL-Lβ, IL-6, and TNF-α as Well as Cyclin E in TNF-α-Created HaCaT Cells: NF-κB and MAPKs as Potential Upstream Targets. International Journal of Molecular Medicine, 19, 469-474.
[120] Soudamini, K.K., Unnikrishnan, M.C., Soni, K.B. and Kuttan, R. (1992) Inhibition of Lipid Peroxidation and Cholesterol Levels in Mice by Curcumin. Indian Journal of Physiology and Pharmacology, 36, 239-243.
[121] Reddy, A.C.P. and Lokesh, B.R. (1994) Dietary Unsaturated Fatty Acids, Vitamin E, Curcumin and Eugenol Alter Serum and Liver Lipid Peroxidation in Rats. Nutrition Research, 14, 1423-1437.
[122] Reddy, A.C.P. and Lokesh, B.R. (1994) Alterations in Lipid Peroxides in Rat Liver by Dietary n-3 Fatty Acids: Modulation of Antioxidant Enzymes by Curcumin, Eugenol, and Vitamin E. Journal of Nutritional Biochemistry, 5, 181-188.
[123] Rukkumani, R., Aruna, K., Varma, P.S., Rajasekaran, K.N. and Menon, V.P. (2004) Comparative Effects of Curcumin and an Analog of Curcumin on Alcohol and PUFA Induced Oxidative Stress. Journal of Pharmacy and Pharmaceutical Sciences, 7, 274-283.
[124] Suryanarayana, P., Saraswat, M., Mrudula, T., Krishna, T.P., Krishnaswamy, K. and Reddy, G.B. (2005) Curcumin and Turmeric Delay Streptozotocin Induced Diabetic Cataract in Rats. Investigative Ophthalmology & Visual Science, 46, 2092-2099.
[125] Thresiamma, K.C., George, J. and Kuttan, R. (1996) Protective Effect of Curcumin, Ellagic Acid and Bixin on Radiation Induced Toxicity. Indian Journal of Experimental Biology, 34, 845-847.
[126] Lawhavinit, O.A., Kongkathip, N. and Kongkathip, B. (2010) Antimicrobial Activity of Curcuminoids from Curcuma longa L. on Pathogenic Bacteria of Shrimp and Chicken. Kasetsart Journal—Natural Science, 44, 364-371.
[127] Mun, S.H., Joung, D.K., Kim, Y.S., et al. (2013) Synergistic Antibacterial Effect of Curcumin against Methicillin-Resistant Staphylococcus aureus. Phytotherapy Research, 19, 599-604.
[128] Rai, D., Singh, J.K., Roy, N. and Panda, D. (2008) Curcumin Inhibits FtsZ Assembly: An Attractive Mechanism for Its Antibacterial Activity. Biochemical Journal, 410, 147-155.
[129] Kaur, S., Modi, N.H., Panda, D. and Roy, N. (2010) Probing the Binding Site of Curcumin in Escherichia coli and Bacillus subtilis FtsZ—A Structural Insight to Unveil Antibacterial Activity of Curcumin. European Journal of Medicinal Chemistry, 45, 4209-4214.
[130] Li, C.J., Zhang, L.J., Dezube, B.J., Crumpacker, C.S. and Pardee, A.B. (1993) Three Inhibitors of Type 1 Human Immunodeficiency Virus Long Terminal Repeat-Directed Gene Expression and Virus Replication. Proceedings of the National Academy of Sciences of the United States of America, 90, 1839-1842.
[131] Chen, D.Y., Shien, J.H., Tiley, L., Chiou, S.S., Wang, S.Y., Chang, T.J., et al. (2010) Curcumin Inhibits Influenza Virus Infection and Haemagglutination Activity. Food Chemistry, 119, 1346-1351.
[132] Zandi, K., Ramedani, E., Mohammadi, K., Tajbakhsh, S., Deilami, I., Rastian, Z., et al. (2010) Evaluation of Antiviral Activities of Curcumin Derivatives against HSV-1 in Vero Cell Line. Natural Product Communications, 5, 1935-1938.
[133] Kutluay, S.B., Doroghazi, J., Roemer, M.E. and Triezenberg, S.J. (2008) Curcumin Inhibits Herpes Simplex Virus Immediate-Early Gene Expression by a Mechanism Independent of p300/CBP Histone Acetyltransferase Activity. Virology, 373, 239-247.
[134] Divya, C.S. and Pillai, M.R. (2006) Antitumor Action of Curcumin in Human Papillomavirus Associated Cells Involves Downregulation of Viral Oncogenes, Prevention of NFκB and AP-1 Translocation, and Modulation of Apoptosis. Molecular Carcinogenesis, 45, 320-332.
[135] Prusty, B.K. and Das, B.C. (2005) Constitutive Activation of Transcription Factor AP-1 in Cervical Cancer and Suppression of Human Papillomavirus (HPV) Transcription and AP-1 Activity in HeLa Cells by Curcumin. International Journal of Cancer, 113, 951-960.
[136] Dutta, K., Ghosh, D. and Basu, A. (2009) Curcumin Protects Neuronal Cells from Japanese Encephalitis Virus-Mediated Cell Death and also Inhibits Infective Viral Particle Formation by Dysregulation of Ubiquitin-Proteasome System. Journal of Neuroimmune Pharmacology, 4, 328-337.
[137] Upendra, R.S., Khandelwal, P. and Reddy, A.H.M. (2011) Turmeric Powder (Curcuma longa Linn.) as an Antifungal Agent in Plant Tissue Culture Studies. International Journal of Engineering Science and Technology, 3, 7899-7904.
[138] Wu, J.H. and Wen, H. (2009) Antifungal Susceptibility Analysis of Berberine, Baicalin, Eugenol and Curcumin on Candida albicans. Journal of Medical Colleges of PLA, 24, 142-147.
[139] Neelofar, K., Shreaz, S., Rimple, B., Muralidhar, S., Nikhat, M. and Khan, L.A. (2011) Curcumin as a Promising Anti-candidal of Clinical Interest. Canadian Journal of Microbiology, 57, 204-210.
[140] Khan, N., Shreaz, S., Bhatia, R., Ahmad, S.I., Muralidhar, S., Manzoor, N. and Khan, L.A. (2012) Anticandidal Activity of Curcumin and Methyl Cinnamaldehyde. Fitoterapia, 83, 434-440.
[141] Sharma, M., Manoharlal, R., Puri, N. and Prasad, R. (2010) Antifungal Curcumin Induces Reactive Oxygen Species and Triggers an Early Apoptosis but Prevents Hyphae Development by Targeting the Global Repressor TUP1 in Candida albicans. Bioscience Reports, 30, 391-404.
[142] Sharma, M., Manoharlal, R., Negi, A.S. and Prasad, R. (2010) Synergistic Anticandidal Activity of Pure Polyphenol Curcumin I in Combination with Azoles and Polyenes Generates Reactive Oxygen Species Leading to Apoptosis. FEMS Yeast Research, 10, 570-578.
[143] Tsao, S.M. and Yin, M.C. (2000) Enhanced Inhibitory Effect from Interaction of Curcumin with Amphotericin B or Fluconazole against Candida Species. Journal of Food and Drug Analysis, 8, 208-212.
[144] Menuel, S., Joly, J.P., Courcot, B., Elysée, J., Ghermani, N.E. and Marsura, A. (2007) Synthesis and Inclusion Ability of a Bis-β-Cyclodextrin Pseudo-Cryptand towards Busulfan Anticancer Agent. Tetrahedron, 63, 1706-1714.
[145] Davis, M.E. and Brewster, M.E. (2004) Cyclodextrin-Based Pharmaceutics: Past, Present and Future. Nature Reviews Drug Discovery, 3, 1023-1035.
[146] Tonnesen, H.H., Másson, M. and Loftsson, T. (2002) Studies of Curcumin and Curcuminoids. XXVII. Cyclodextrin Complexation: Solubility, Chemical and Photochemical Stability. International Journal of Pharmaceutics, 244, 127-135.
[147] Aqil, F., Munagala, R., Jeyabalan, J. and Vadhanam, M.V. (2013) Bioavailability of Phytochemicals and Its Enhancement by Drug Delivery Systems. Cancer Letters, 334, 133-141.
[148] 1Yallapu, M.M., Jaggi, M. and Chauhan, S.C. (2010) β-Cyclodextrin-Curcumin Self-Assembly Enhances Curcumin Delivery in Prostate Cancer Cells. Colloids and Surfaces B: Biointerfaces, 79, 113-125.
[149] Yadav, V.R., Prasad, S., Kannappan, R., Ravindran, J., Chaturvedi, M.M., Vaahtera, L., et al. (2010) Cyclodextrin-Complexed Curcumin Exhibits Anti-Inflammatory and Antiproliferative Activities Superior to Those of Curcumin through Higher Cellular Uptake. Biochemical Pharmacology, 80, 1021-1032.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.